HPlot: A novel quantitative framework for spatial profiling of Immune heterogeneity in tumor microenvironments

AACR 2026

Apr 03, 2026
Oncology
Abstract

Chao Hui Huang, Jadwiga Renata Bienkowska, Diane Fernandez, Sara Beth Linker, Xinmeng Jasmine Mu, Robbin Nameki, Jennifer Kinong, Michelle Saul, Aakash Sur, Mehmet Tekman, Alexander Trageser, Wenjing Yang, Daniel Chawla, Greg Szeto, Arne Schmidt, Alberto M. Gonzalo, Srishti Munjal Mehta, Rosemarie Krupar, Nina Kozar-Gillan, Sophie Laturnus, Cornelius Böhm, Marija Pezer, Gloria H.Y. Lin, Darlan Conterno Minussi, Keith Ching, Thomas Powles, Craig Davis

Spatial organization of immune and tumor cells plays a critical role in disease progression and therapeutic response. Existing spatial analysis methods often treat tissue regions as uniform compartments and fail to quantify how immune composition and functional states change across tumor boundaries. This limits the ability to detect spatial biomarkers associated with treatment outcomes. We developed H-Plot, a quantitative framework for profiling spatial immune heterogeneity with high resolution. The method is compatible with whole-slide imaging and modern single-cell spatial biology platforms. H-Plot integrates three components: (1) Cell prediction and classification using machine-learning-based single-cell image analysis or spatial transcriptomics-derived cell subtyping to generate a high-fidelity cellular map; (2) Cell-function enrichment analysis to identify biologically meaningful structures such as tumor regions, lymphoid aggregates, and tertiary lymphoid structures (TLS) through localized functional program detection; and (3) Cell spatial profiling, which measures spatial relationships and computes layer-wise distances from biological structure boundaries (e.g., tumor margins) to capture spatial gradients across the tumor-immune interface. Applying H-Plot to the ABACUS bladder cancer dataset revealed that treatment responders exhibited higher lymphocyte enrichment adjacent to tumor borders and smoother immune-layer transitions, whereas non-responders showed shallow or fragmented infiltration. In the TEMPUS mCRPC cohort, reduced pre-treatment lymphocyte proximity and weaker enrichment layers were associated with poorer clinical outcomes and aligned with RNA-based immune signatures and histological assessments.H-Plot provides a reproducible, interpretable, and visualization-ready framework for quantifying tumor-immune spatial heterogeneity. By converting complex spatial arrangements into layer-wise quantitative profiles and intuitive visualizations, H-Plot enables systematic comparison across patients, treatments, and tumor types. This framework supports spatial biomarker discovery and offers a scalable tool for translational oncology research.